Signaling Pathways - Mixed lineage kinase domain-like protein (MLKL) - Angiotensin AT2 Receptors - Calcium-Activated Potassium (KCa) Channels - 5-HT7 Receptors
清除全部
-
B7731 Necrosulfonamide1 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: 坏死抑制剂 -
B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂 -
B1477 Lurasidone HCl中文名: 盐酸鲁拉西酮Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂 -
B1490 Quetiapine Fumarate1 Citation中文名: 富马酸奎硫平Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺受体拮抗剂 -
B2206 PD123319Target: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体的拮抗剂 -
A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药 -
A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂 -
A3926 Vortioxetine中文名: 沃替西汀Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERTSummary: 5-HT受体拮抗剂 -
A3704 PD 123319 ditrifluoroacetateTarget: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体拮抗剂